There were no differences in IL-1β levels among the groups, but controls had substantially higher levels of IL-6 than the APL and PJI groups, whereas APL patients had higher TNF-α serum levels than the other two groups. This evidence concerns the gene IL6 and acute promyelocytic leukemia.